Nobel Prize in Chemistry was awarded for AI innovations in protein structure prediction, revolutionising drug development.

Eurofins Healthcare Assurance expands to China, offering enhanced local support and global expertise in safety and quality ...

New study shows E. coli resists antibiotics by modifying its ribosome structure, blocking drug binding and enabling growth despite treatment. The researchers found that, when exposed to antibiotics, E ...

Explore the step-by-step scientific workflow behind drug discovery, from formulating hypotheses to analysing data, ensuring accurate and reliable results. In drug discovery and biological research, ...

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

Halozyme Therapeutics, a biotechnology company based in San Diego, has made a €2 billion offer to acquire Evotec SE, a leading global drug discovery firm. If successful, this acquisition aims to unite ...

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

article Unlocking a new molecular space in rapid drug discovery 23 October 2024 | By Dr Jorg Scheuermann (ETH Zurich), Dr Michelle Keller (ETH Zurich) So-called undruggable pharmaceutical targets ...

Insilico Medicine’s AI-designed drug ISM5939 has received FDA IND clearance for treating solid tumours. By targeting ENPP1, it enhances anti-tumour immunity and is set to begin Phase I trials soon.

Find out how Confo Therapeutics is overcoming challenges in GPCR drug development to create next-gen therapies for metabolic diseases.